HCPCS Q9991 is officially defined as "Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg." HCPCS Q9991 is referenced in 4 tracked payer policy changes from CareSource, Oregon Health Plan, and 1 other payer. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS Q9991 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.